Abstract
In 56 pediatric and adolescent patients (median age 7 years, range 1–21) with various solid tumors, peripheral blood stem cells (PBSC) were mobilized with granulocyte colony-stimulating factor (G-CSF) alone, and the yields of PBSC and engraftment kinetics following autologous peripheral blood stem cell transplantation (PBSCT) were evaluated retrospectively. Granulocyte colony-stimulating factor (10 μg/kg) was injected subcutaneously for mobilization when patients showed no influence of previous chemotherapy, and administration was continued for 5 days. The peaks of CD34+ cells and colony-forming units-granulocyte/macrophage in the blood were observed on days 4 through 6 of G-CSF administration in all patients. Peripheral blood stem cell harvest was commenced on day 5 of G-CSF treatment. Compared to the results in patients mobilized by chemotherapy plus G-CSF (N=18), the progenitor cell yields were lower in patients mobilized with G-CSF alone. However, there were no significant differences in WBC and ANC engraftment compared to the chemotherapy plus G-CSF mobilization group. Platelet recovery following autologous PBSCT was delayed in patients mobilized with G-CSF alone. The median time taken for ANC and platelet counts to reach 0.5 × 109 and 20 × 109/l was 12 days (range: 9–28) and 15 days (8–55), respectively, in all patients who received PBSC mobilized by G-CSF alone. In summary, mobilization with G-CSF alone can mobilize sufficient CD34+ cells for successful autografting and sustained hematological reconstitution in pediatric and adolescent patients with solid tumors, and even in heavily pre-treated patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Handgretinger R, Lang P, Ihm K, Schumn M, Geiselhart A, Koscielniak E et al. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma. Bone Marrow Transplant 2002; 29: 731–736.
Arpaci F, Ataergin S, Ozet A, Erler K, Basbozkurt M, Ozcan A et al. The feasibility of neoadjuvant high-dose chemotherapy and autologous blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma. Cancer 2005; 104: 1058–1065.
To LB, Haylock DN, Simmons PJ, Juttner CA . The biology and clinical uses of blood stem cells. Blood 1997; 89: 2233–2258.
Diaz MA, Vincent M, Garcia-Sanchez F, Vicario JL, Madero L . Long-term hematopoietic engraftment after autologous peripheral blood progenitor cell transplantation in pediatric patients: effect of the CD34+ cell dose. Vox Sang 2000; 79: 145–150.
Dazzi C, Cariello A, Rosti G, Argnani M, Sebastiani L, Ferrari E et al. Is there any difference in PBPC mobilization between cyclophosphamide plus G-CSF and G-CSF alone in patients with non-Hodgkin's lymphoma? Leuk Lymphoma 2000; 39: 301–310.
Meldgaard-Knudsen L, Jensen L, Gaarsdal E, Nikolaisen K, Johnsen HE . A comparative study of sequential priming and mobilization of progenitor cells with rG-CSF alone and high-dose cyclophosphamide plus rG-CSF. Bone Marrow Transplant 2000; 26: 717–722.
Nakayanasami U, Kanteti R, Morelli J, Klekar A, Al-Olama A, Keating C et al. Randomized trail of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cell rescue in autologous transplantation. Blood 2001; 98: 2059–2064.
Karanth M, Chakrabarti S, Lovell RA, Harvey C, Holder K, McConkey CC et al. A randomized study comparing peripheral blood progenitor mobilisation using intermediate-dose cyclophosphamide plus lenograstim with lenograstim alone. Bone Marrow Transplant 2004; 34: 399–403.
Seggewiss R, Buss EC, Herrmann D, Goldschmit H, Ho AD, Fruenhauf S . Kinetics of peripheral blood stem cell mobilization following G-CSF-supported chemotherapy. Stem Cells 2003; 21: 568–574.
Suh C, Kim S, Kim S, Kim EK, Lee JL, Park KU et al. Initiation of peripheral blood progenitor cell harvest based on peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE9000. Transfusion 2004; 44: 1762–1768.
Anderlini P, Körbling M . The use of mobilized peripheral blood stem cells from normal donors for allografting. Stem Cells 1997; 15: 9–17.
Takaue Y, Kawano Y, Abe T, Okamoto Y, Suzue T, Shimizu T et al. Collection and transplantation of peripheral blood stem cells in very small children weighing 20 kg or less. Blood 1995; 86: 372–380.
Yu J, Leisenring W, Bensinger WI, Holmberg LA, Rowley SD . The predictive value of white cell or CD34+ cell count in peripheral blood for timing apheresis and maximizing yield. Transfusion 1999; 39: 442–450.
Gojo I, Guo C, Sarkodee-Adoo C, Meisenberg B, Fassas A, Rapoport AP et al. High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficiency and toxicity. Bone Marrow Transplant 2004; 34: 69–76.
Kuittinen T, Nousiainen T, Halonen P, Mahlamaki E, Jantunen E . Prediction of mobilization failure in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 2004; 33: 907–912.
Canales MA, Fernandez-Jimenez MC, Martin A, Arrieta R, Caballero MD, Diez J et al. Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease. Haematologica 2001; 86: 494–498.
Ford CD, Green W, Warenski S, Petersen FB . Effects of prior chemotherapy on hematopoietic stem cell mobilization. Bone Marrow Transplant 2004; 33: 901–905.
Carral A, de la Rubia J, Martin G, Molla S, Martinez J, Sanz GF et al. Factors influencing the collection of peripheral blood stem cell in patients with acute myeloblastic leukemia and non-myeloid malignancies. Leuk Res 2003; 27: 5–12.
Koumakis G, Vassiolmanolakis M, Hatzichristou H, Barbounis V, Fillis J, Papanastasiou K et al. Predictive factors affecting mobilization and peripheral blood stem cell collection using single apheresis for rescuing patients after high-dose chemotherapy in various malignancies. Bone Marrow Transplant 1996; 18: 1065–1072.
Noach EJK, Ausema A, van Os R, Akkerman I, Koopal S, Weesing E . Chemotherapy prior to autologous bone marrow transplantation impairs long-term engraftment. Exp Hematology 2003; 31: 528–534.
Diaz MA, Villa M, Alegre A, Lamana ML, de la Vega A, Granda A et al. Collection and transplantation of peripheral blood progenitor cells mobilized by G-CSF alone in children with malignancies. Br J Haematol 1996; 94: 148–154.
Acknowledgements
We are grateful to Ms A Itho for her technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Watanabe, H., Watanabe, T., Suzuya, H. et al. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor. Bone Marrow Transplant 37, 661–668 (2006). https://doi.org/10.1038/sj.bmt.1705304
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705304